Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Voyager Therapeutics, Inc. (VYGR) had Free Cash Flow per Share of $-0.56 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.59M |
|
$-27.94M |
|
-- |
|
$2.59M |
|
$32.86M |
|
$-30.27M |
|
$2.35M |
|
$-27.92M |
|
$-27.92M |
|
$-27.94M |
|
$-27.94M |
|
$-27.94M |
|
$-27.94M |
|
$-30.27M |
|
$-29.70M |
|
59.50M |
|
59.50M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$146.98M |
|
$12.22M |
|
$72.34M |
|
$219.32M |
|
$17.45M |
|
-- |
|
$28.20M |
|
$45.66M |
|
$173.67M |
|
$173.67M |
|
$173.67M |
|
60.31M |
|
| Cash Flow Statement Financials | |
$-33.42M |
|
$8.10M |
|
$3.33M |
|
$68.04M |
|
$46.05M |
|
$-21.99M |
|
$2.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1167.37% |
|
-1167.37% |
|
-- |
|
-1076.86% |
|
-1077.40% |
|
$-33.43M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.58 |
|
57.10 |
|
-16.09% |
|
-16.09% |
|
-12.74% |
|
-16.09% |
|
$2.88 |
|
|
Free Cash Flow per Share |
$-0.56 |
$-0.56 |
|